Night movers — Oct 13: Banks and chips stumble as post-earnings pressure meets an after-midnight tech rebound
After-midnight gainers were led by ORCL up 4.23%, META up 2.63%, NIO up 2.59%, AMD up 1.90%, and VZ up 1.75%. Decliners were led by JNJ down 5.73%, C down 5.60%, WFC down 3.10%, IQ down 2.75%, and LRCX down 2.73%.
Idea
## Session overview After-midnight gainers were led by ORCL up 4.23%, META up 2.63%, NIO up 2.59%, AMD up 1.90%, and VZ up 1.75%. Decliners were led by JNJ down 5.73%, C down 5.60%, WFC down 3.10%, IQ down 2.75%, and LRCX down 2.73%. ## Compared with previous session META and VZ extended their gains from the prior night, when they rose 3.38% and 2.71%, though META's advance slowed to 2.63%. ORCL and NIO flipped from prior-night losses of 2.84% and 3.07% to gains of 4.23% and 2.59%, while LRCX fell again after sliding 2.91% previously. ## Gainers - **ORCL +4.23%** — No matching ingested catalyst was found for ORCL. The move is reported without a news attribution. - **META +2.63%** — Meta shares rose for a second straight day as its new AI model family impressed investors. Mark Zuckerberg claimed the newest Muse and Wonder models rival OpenAI and Anthropic, calling them a step toward personal superintelligence. - **NIO +2.59%** — No matching ingested catalyst was found for NIO. The move is reported without a news attribution. - **AMD +1.90%** — China's leading memory chipmaker CXMT reportedly made progress on new designs, contributing to a global stock rout. The report landed amid broader pressure on US chip stocks tied to AI spending jitters. - **VZ +1.75%** — SpaceX's spectrum push has rattled Verizon, AT&T and T-Mobile as analysts map out several paths for Starlink to challenge US wireless. The coverage underscores a real competitive threat to telecom incumbents even as VZ traded higher. ## Losers - **JNJ -5.73%** — J&J beat earnings estimates, but Middle East conflict weighed on medical-device sales, with the medtech division up just 2.5% versus 7.7% pharma growth. The company also raised its profit guidance and laid out plans for a mid-2027 hip and knee unit spinoff. - **C -5.60%** — Citigroup reported third-quarter results during a bank earnings session in which big US banking stocks were already firmly in correction territory. Citi's fixed-income traders beat expectations with their best third quarter in at least a decade, offsetting a more sluggish M&A advisory business. - **WFC -3.10%** — Wells Fargo reported third-quarter results as part of the kickoff of US earnings season, with the KBW Bank Index down around 12% from its mid-August peak. Despite a Reuters report that profit rose on robust loan growth and interest income, the stock traded lower. - **IQ -2.75%** — No matching ingested catalyst was found for IQ. The move is reported without a news attribution. - **LRCX -2.73%** — No matching ingested catalyst was found for LRCX. The move is reported without a news attribution.
Advanced Analysis — institutional-depth research report
Verdict: a strong quarter, but ORCL dip-buying stays on the watch list
The idea is a patient mean-reversion buy on ORCL: wait for a pullback that reverses with the close above the 50-day EMA, the RSI crossing 40, and a close back inside the Bollinger middle band. The strongest case for the trade is Oracle's fiscal first quarter ended August 31, 2026 — revenue of $19.3B running 20.6% above a year earlier, operating margin up to 34.8%, and operating cash flow up 58% to $23.1B — exactly the kind of business where buying weakness has worked. The strongest case against is the cash picture and insider posture: free cash flow was negative $5.4B (worse than the prior quarter), and provisional ownership filings for the period ended September 30, 2026 show net open-market insider selling of roughly $45.0M, which argues against buying the dip aggressively. The live technicals are close but unconfirmed: ORCL closed at $132.55 with RSI at 37.9, below the 50-day EMA at $144.51 and the middle band at $141.31, and the rules produced zero entries across 1,236 daily bars in five years — this is a watch-list setup, not a signal. Because the parameter-sensitivity evaluation exceeded its time budget, no robust nearby-parameter setup was established, so the live thresholds stay as the thesis-consistent defaults. The verdict: wait for the retrace-plus-reclaim pattern, and let the next earnings report be the tiebreaker.
Trade now: ORCL is oversold, but the reversal entry has not armed yet
This is a watch-list setup on ORCL, not an active signal. The strategy is a long entry on ORCL's daily bars that requires four things at once: the close above the 50-day EMA (currently 144.51), the 14-day RSI crossing above 40, the close below the Bollinger middle band (currently 141.31), and the day's low touching the nearest support level at 131.58. Right now ORCL sits at 132.55 with RSI at 37.9 — one condition (price below the middle band) is met, but price is $11.96 below the EMA trigger, RSI is 2.1 points below the 40 line, and the support-touch condition has not been confirmed with an entry. In other words, the stock is oversold but has not yet turned. What does waiting mean concretely? Two paths can arm this setup. First, a sharp washout toward or below the 131.58 support followed by a rebound that pushes the close back above the 141.31 middle band, above the 144.51 EMA, and RSI back over 40 — a deep-pullback reversal. Second, a sideways consolidation that lets the falling EMA converge toward price while RSI recovers through 40 near the band. Until price reclaims roughly 144.5 with RSI above 40 while closing inside the band, there is no trade. Risk framing once triggered: the fixed stop sits at a 2.5% loss from entry, with a hard stop also active if the close falls back above the second support level (134.57), and the take-profit ladder targets the first resistance at 146.74 or a 5.1% gain, whichever comes first. That gives roughly 2:1 reward-to-risk on the fixed bracket. Position sizing is fixed-risk at 2.5% of capital per trade with a maximum 25% of the book in one name. One caveat on tuning: the author requested a bounded parameter optimization, but the sensitivity evaluation exceeded its time budget, so no robust nearby-parameter recommendation was established — the live thresholds are the thesis-consistent defaults. The recent session context matters too: ORCL jumped 4.23% in the latest night session per the idea's summary, so momentum may recover faster than the entry conditions allow; chasing the bounce is not the strategy, waiting for the retrace-plus-reclaim pattern is.
ORCL's fundamentals give the pullback-buying setup something to stand on
The operating picture at Oracle is genuinely strong right now. In its fiscal first quarter ended August 31, 2026, revenue reached $19.3B, up 0.8% from the prior quarter and running 20.6% above the year-ago level — a growth rate that places Oracle around the 75th percentile among 899 Information Technology peers. Operating margin expanded to 34.8% from 32.0% the quarter before, in the top 4% of the sector, while net income rose 13.3% to $4.76B and net margin climbed to 24.6%. These are the kinds of fundamentals that justify the thesis's interest in buying weakness in this name rather than weakness in a deteriorating business. The strategy's construction also aligns with how ORCL actually trades. The idea waits for a pullback toward the 50-day average or the lower volatility band with momentum turning up — a support-and-reversal entry on daily bars. After a 4.23% one-session surge, buying a discount toward the mean is a coherent plan for a stock capable of moving that much in a single session. A take-profit at 5.1% against a 2.5% stop, sized at a fixed 2.5% risk per position, keeps the reward-to-risk profile disciplined. The dividend record reinforces the quality profile. Oracle has raised its payout from $1.20 per share in 2021 to $2.00 for 2026 — roughly 5.3% annual growth — with the most recent quarterly payment of $0.50 going ex on October 9, 2026. Growing shareholder returns alongside top-decile operating margins is exactly the backdrop in which mean-reversion buying has historically tended to work best. Note the evidence scope honestly: the rules were evaluated on 1,236 real daily bars over the last five years but did not open an entry in that window, so this is a watch-list setup rather than an active signal. That is a statement about how often ORCL pulls back this far while still holding its 50-day line — not about the quality of the data. When (and if) the conditions do fire, the fundamental case above is what carries the trade.
A cash-burning stock with net insider selling — and an entry that has never fired
The most serious fundamental problem is cash flow. Oracle's free cash flow was negative $5.4B in the fiscal first quarter ended August 31, 2026 — worse than the negative $1.9B the prior quarter — and it sits at roughly the 0.5th percentile among 833 Information Technology peers. The company is funding an enormous data-center buildout with $16.5B of capital expenditure in the latest fiscal year, and interest expense of $1.4B per quarter against a debt-to-equity ratio that was still about 3.0 in fiscal 2026. A strategy that buys ORCL dips is exposed to the possibility that this investment cycle squeezes the balance sheet before the growth shows up in cash. Insider posture is adverse too. Filings for the period ended September 30, 2026 (provisional data, so figures may still be revised) show net open-market insider selling of roughly $45.0M at Oracle, across 131 institutional holders. Management upheaval compounds the caution: the fiscal 2026 proxy lists two co-CEOs — Michael Sicilia and Clayton Magouyrk — while 81-year-old founder Larry Ellison remains Executive Chairman and CTO and Safra Catz has shifted to Executive Vice Chair. Transitions of this scale create execution and communication risk precisely when the capex story needs flawless delivery. The volatility math is uncomfortable in plain language. This stock regularly swings 3-5% in a single session — it lost 2.84% one night and gained 4.23% the next, per the idea's own session summary. A hard stop at 2.5% below entry can be brushed aside by an ordinary gap, meaning realized losses could exceed the nominal stop on fast sessions. Finally, the setup itself has not appeared in years: the entry rules — a close above the 50-day average combined with an RSI crossing above 40 while price sits below the middle Bollinger band at a support level — did not trigger once across 1,236 daily bars in the last 60 months. No robust parameter setup was established because the parameter-sensitivity evaluation exceeded its time budget, so there is no evidence the thresholds were tuned to ORCL's actual behavior. And the broader tape argues against contrarian dip-buying here: JNJ fell 5.73% despite beating estimates, Citi dropped 5.60% on strong results amid a bank correction, and CXMT news triggered a global chip rout that dragged AMD and LRCX. Buying strength-driven pullbacks in this regime is a bet against the current market's own message.
Company context
### ORCL **Ownership and insiders.** For the period ending 2026-09-30, 131 reporting holders were counted holding 3331521 reported shares. Insider filings indicate net open-market selling, netting US$-44970616.08. Coverage: Provisional. **Management.** Mr. Michael D. Sicilia is identified as chief executive. Mr. Michael D. Sicilia is listed as Chief Executive Officer & Director, with reported total pay of US$7.9M for fiscal 2026. Source: [Yahoo Finance quoteSummary](https://finance.yahoo.com/quote/ORCL/profile), retrieved 2026-10-14T13:52:58.57+00:00. **Dividends.** Trailing twelve-month distributions total USD 2 per share; the latest observed ex-date was 2026-10-09 at USD 0.5 per share. The latest annual comparison is +5.3%. Source: [Yahoo Finance corporate actions](https://finance.yahoo.com/quote/ORCL/history?filter=div), retrieved 2026-10-14T13:52:58.57+00:00. **Fundamental changes.** Latest reported comparisons: - Free cash flow: USD -5.4B for Q1 ending 2026-08-31 versus USD -1.9B for Q4 ending 2026-05-31 · quarter over quarter - Net Income: USD 4.8B for Q1 ending 2026-08-31 versus USD 4.2B for Q4 ending 2026-05-31 (+13.3%) · quarter over quarter - Net margin: 24.6% for Q1 ending 2026-08-31 versus 21.8% for Q4 ending 2026-05-31 (+2.7 percentage points) · quarter over quarter - Operating Cash Flow: USD 23.1B for Q1 ending 2026-08-31 versus USD 14.6B for Q4 ending 2026-05-31 (+58.0%) · quarter over quarter - Operating margin: 34.7% for Q1 ending 2026-08-31 versus 31.9% for Q4 ending 2026-05-31 (+2.8 percentage points) · quarter over quarter - Revenue: USD 19.3B for Q1 ending 2026-08-31 versus USD 19.2B for Q4 ending 2026-05-31 (+0.8%) · quarter over quarter Source: Reported company financial data. Comparisons use consecutive reported periods at the same cadence and compatible units. Relative percentage changes require a positive baseline; rate changes are expressed in percentage points. **Unavailable comparisons.** - Debt to equity: The latest period's value is unavailable. - Gross margin: The latest period's value is unavailable. - Return on equity: The previous period's value is unavailable. - Shares Outstanding: The previous period's value is unavailable. ### META **Ownership and insiders.** For the period ending 2026-09-30, 211 reporting holders were counted holding 4117055 reported shares. Insider filings indicate net open-market selling, netting US$-57416067.16. Coverage: Provisional. **Management.** Mr. Mark Elliot Zuckerberg is identified as chief executive. Mr. Mark Elliot Zuckerberg is listed as Founder, Chairman & CEO, with reported total pay of US$25.1M for fiscal 2025. Source: [Yahoo Finance quoteSummary](https://finance.yahoo.com/quote/META/profile), retrieved 2026-10-14T13:52:58.57+00:00. **Dividends.** Trailing twelve-month distributions total USD 2.1 per share; the latest observed ex-date was 2026-09-21 at USD 0.525 per share. The latest annual comparison is +1.2%. Source: [Yahoo Finance corporate actions](https://finance.yahoo.com/quote/META/history?filter=div), retrieved 2026-10-14T13:52:58.57+00:00. **Fundamental changes.** Latest reported comparisons: - Free cash flow: USD 1.7B for Q2 ending 2026-06-30 versus USD 13.2B for Q1 ending 2026-03-31 (-86.8%) · quarter over quarter - Gross margin: 81.3% for Q2 ending 2026-06-30 versus 81.8% for Q1 ending 2026-03-31 (-0.5 percentage points) · quarter over quarter - Net Income: USD 15.8B for Q2 ending 2026-06-30 versus USD 26.8B for Q1 ending 2026-03-31 (-40.8%)…
Scores
- Conviction score breakdown: 52
- Thesis support: 65
- Trade readiness: 45
- Risk quality: 50
- Trigger proximity: 40
- Fundamentals trend: 60
Watch items
- ORCL — ORCL daily close vs 50-day EMA
- ORCL — ORCL RSI (14)
- ORCL — ORCL close vs Bollinger middle band
- ORCL — ORCL daily low vs nearest support
- ORCL — ORCL insider net open-market selling (provisional, period ending 2026-09-30)
- ORCL — ORCL trailing 12-month dividend per share
Key details
Community
News sources
- Meta shares rise for a second straight day as new AI model family impresses — CNBC Top News
- Meta claims new Muse Wonder AI models rival OpenAI, Anthropic — CoinTelegraph
- Why this little known Chinese chipmaker has caused a global stock rout — CNBC Top News
- The SpaceX threat to telecom is real. How it could play out — CNBC Top News
- J&J beats earnings estimates; Middle East conflict weighs on medical-device sales — CNBC Top News
- J&J beats earnings estimates, eyes mid-2027 hip and knee unit spinoff - Reuters — Reuters
- Bank earnings live updates: JPMorgan, Wells Fargo, Goldman Sachs and Citigroup report — CNBC Top News
- Chip Selloff Deepens Before Wall Street Earnings — Bloomberg Markets
- Citi’s Fixed Income Traders Drive Third-Quarter Beat on Revenue — Bloomberg Markets